| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
BNTX
BioNTech SE
|
Aug 28, 2026 | BUY |
Strong Buy
+32.9% avg upside
26 analysts
|
$128.00
25.30% Upside
|
· | · |
|
GILD
Gilead Sciences
|
Aug 27, 2026 | BUY |
Strong Buy
-18.8% avg upside
66 analysts
|
$174.00
19.38% Upside
|
+0.0% | · |
|
SRRK
Scholar Rock Holding
|
Aug 21, 2026 | BUY |
Strong Buy
+1.2% avg upside
23 analysts
|
$76.00
31.41% Upside
|
+4.9% | · |
|
MRK
Merck & Company
|
Aug 20, 2026 | BUY |
Strong Buy
-8.4% avg upside
43 analysts
|
$170.00
14.68% Upside
|
-0.4% | · |
|
ASND
Ascendis Pharma
|
Aug 18, 2026 | BUY |
Strong Buy
+13.7% avg upside
26 analysts
|
$319.00
28.70% Upside
|
-0.4% | · |
|
VRTX
Vertex Pharmaceuticals
|
Aug 17, 2026 | BUY |
Strong Buy
-17.8% avg upside
62 analysts
|
$600.00
10.66% Upside
|
+6.2% | · |
|
REGN
Regeneron
|
Aug 17, 2026 | BUY |
Strong Buy
-0.9% avg upside
58 analysts
|
$800.00
0.69% Upside
|
+1.2% | · |
|
PFE
Pfizer
|
Aug 17, 2026 | BUY |
Buy
+19.9% avg upside
45 analysts
|
$30.00
7.20% Upside
|
+4.1% | · |
|
NVO
Novo Nordisk
|
Aug 17, 2026 | HOLD |
Buy
+154.4% avg upside
26 analysts
|
$47.00
3.00% Upside
|
+1.6% | · |
|
NBIX
Neurocrine
|
Aug 17, 2026 | HOLD |
Strong Buy
+21.6% avg upside
37 analysts
|
$190.00
23.27% Upside
|
-0.7% | · |
|
INCY
Incyte
|
Aug 17, 2026 | HOLD |
Buy
-12.2% avg upside
48 analysts
|
$130.00
4.45% Upside
|
+0.7% | · |
|
LLY
Eli Lilly & Co
|
Aug 17, 2026 | BUY |
Strong Buy
-10.1% avg upside
48 analysts
|
$1400.00
19.10% Upside
|
-1.4% | · |
|
AMGN
Amgen
|
Aug 17, 2026 | BUY |
Buy
-25.9% avg upside
57 analysts
|
$450.00
3.97% Upside
|
+3.7% | · |
|
BMY
Bristol-Myers Squibb
|
Aug 17, 2026 | HOLD |
Buy
-8.3% avg upside
42 analysts
|
$60.00
9.80% Downside
|
+3.0% | · |
|
ABCL
AbCellera Biologics
|
Aug 17, 2026 | BUY |
Strong Buy
+41.0% avg upside
15 analysts
|
$15.00
32.23% Upside
|
+7.3% | · |
|
SDGR
Schrodinger
|
Aug 17, 2026 | BUY |
Strong Buy
+39.9% avg upside
15 analysts
|
$24.00
21.85% Upside
|
+17.3% | · |
|
REPL
Replimune Group
|
Aug 17, 2026 | BUY |
Strong Buy
+49.0% avg upside
14 analysts
|
$20.00
29.08% Upside
|
+5.9% | · |
|
PTGX
Protagonist Therapeutics
|
Aug 17, 2026 | BUY |
Strong Buy
-16.6% avg upside
19 analysts
|
$178.00
23.26% Upside
|
-9.0% | · |
|
TSE:APTX
Apotex Health Corp.
|
Aug 12, 2026 | BUY |
Strong Buy
+26.8% avg upside
10 analysts
|
$43.00
34.91% Upside
|
-9.3% | · |
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
Aug 06, 2026 | BUY |
Strong Buy
+118.5% avg upside
17 analysts
|
$145.00
206.09% Upside
|
-10.0% | · |
|
ACAD
ACADIA Pharmaceuticals
|
Aug 04, 2026 | BUY |
Strong Buy
+26.9% avg upside
43 analysts
|
$36.00
23.63% Upside
|
+7.2% | · |
|
BIIB
Biogen
|
Jul 30, 2026 | HOLD |
Strong Buy
+16.1% avg upside
52 analysts
|
$208.00
4.81% Downside
|
+6.5% | · |
|
MPLT
MapLight Therapeutics, Inc.
|
Jul 27, 2026 | BUY |
Strong Buy
+134.8% avg upside
13 analysts
|
$20.00
58.78% Upside
|
+13.2% | · |
|
ABBV
AbbVie
|
Jul 13, 2026 | BUY |
Strong Buy
-5.6% avg upside
46 analysts
|
$300.00
17.42% Upside
|
+3.8% | · |
|
TSHA
Taysha Gene Therapies
|
Jun 30, 2026 | BUY |
Strong Buy
+144.7% avg upside
21 analysts
|
$14.00
142.59% Upside
|
-15.3% | · |
|
IRON
Disc Medicine
|
Jun 02, 2026 | BUY |
Strong Buy
+9.3% avg upside
21 analysts
|
$100.00
24.86% Upside
|
+17.7% | · |
|
ARVN
Arvinas Holding Company
|
Sep 30, 2025 | HOLD |
Buy
+211.7% avg upside
28 analysts
|
— | +9.7% | · |
|
NGNE
Neurogene
|
Sep 30, 2025 | HOLD |
Strong Buy
+33.0% avg upside
23 analysts
|
— | +118.5% | · |
|
CCCC
C4 Therapeutics
|
May 06, 2025 | HOLD |
Strong Buy
+363.8% avg upside
19 analysts
|
— | +107.8% | · |
|
DE:MRK
Merck KGaA
|
Oct 23, 2024 | BUY |
Buy
-1.7% avg upside
33 analysts
|
$128.75
8.13% Downside
|
-24.6% | · |
|
CADL
Candel Therapeutics
|
Aug 07, 2023 | HOLD |
Strong Buy
+40.5% avg upside
11 analysts
|
— | +369.2% | · |
|
NUVB
Nuvation Bio
|
May 09, 2023 | HOLD |
Strong Buy
+99.2% avg upside
17 analysts
|
— | +106.8% | · |
|
IMA
ImageneBio
|
Aug 13, 2021 | BUY |
Buy
+235.1% avg upside
13 analysts
|
$27.00
405.58% Upside
|
· | · |
|
OBX
Obsidian Therapeutics
|
Dec 16, 2020 | BUY |
Strong Buy
-13.7% avg upside
10 analysts
|
$15.00
8.05% Downside
|
· | · |
|
NL:LKFT
Galapagos
|
Oct 16, 2020 | HOLD |
Sell
+109.4% avg upside
16 analysts
|
$129.00
415.57% Upside
|
-58.7% | · |
|
TLPH
Talphera
|
Aug 13, 2020 | SELL |
Buy
+292.7% avg upside
15 analysts
|
$0.84
30.06% Downside
|
· | · |
|
MGNX
MacroGenics
|
May 11, 2020 | BUY |
Buy
+329.8% avg upside
25 analysts
|
$30.00
626.48% Upside
|
+16.1% | · |
|
LKFT
Lakefront Biotherapeutics
|
Feb 24, 2020 | HOLD |
Buy
+266.0% avg upside
24 analysts
|
$220.00
661.75% Upside
|
-65.5% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.